Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17M Sell
32,439
-448
-1% -$52.4K 0.84% 30
2026
Q1
$3.96M Sell
32,887
-54
-0.2% -$6.23K 0.88% 26
2025
Q4
$3.47M Buy
32,941
+31,854
+2,930% +$2.99M 0.75% 36
2025
Q3
$91.2K Buy
1,087
+5
+0.5% +$412 0.02% 224
2025
Q2
$85.7K Buy
1,082
+627
+138% +$49.8K 0.02% 229
2025
Q1
$40.8K Buy
455
+10
+2% +$934 0.01% 235
2024
Q4
$44.3K Sell
445
-9,849
-96% -$1.02M 0.01% 233
2024
Q3
$1.17M Buy
10,294
+945
+10% +$112K 0.3% 102
2024
Q2
$1.16M Buy
9,349
+352
+4% +$45.3K 0.31% 97
2024
Q1
$1.19M Buy
8,997
+484
+6% +$59.7K 0.33% 92
2023
Q4
$935K Sell
8,513
-220
-3% -$22.8K 0.28% 111
2023
Q3
$905K Buy
8,733
+591
+7% +$63.7K 0.3% 104
2023
Q2
$940K Buy
8,142
+9
+0.1% +$1.02K 0.31% 106
2023
Q1
$871K Buy
8,133
+524
+7% +$56.6K 0.29% 101
2022
Q4
$850K Sell
7,609
-47
-0.6% -$4.8K 0.31% 101
2022
Q3
$660K Buy
7,656
+90
+1% +$8.03K 0.26% 122
2022
Q2
$695K Buy
7,566
+6,823
+918% +$605K 0.27% 123
2022
Q1
$61K Sell
743
-33
-4% -$2.6K 0.02% 250
2021
Q4
$59K Hold
776
0.02% 253
2021
Q3
$59K Buy
776
+198
+34% +$15.1K 0.02% 244
2021
Q2
$45K Sell
578
-28
-5% -$2.08K 0.02% 263
2021
Q1
$45K Sell
606
-12,708
-95% -$937K 0.02% 247
2020
Q4
$1.05M Sell
13,314
-7,608
-36% -$582K 0.44% 81
2020
Q3
$1.66M Buy
20,922
+10,150
+94% +$795K 0.78% 37
2020
Q2
$801K Buy
10,772
+279
+3% +$21K 0.43% 73
2020
Q1
$777K Buy
10,493
+1,048
+11% +$82.4K 0.54% 52
2019
Q4
$820K Sell
9,445
-649
-6% -$53.3K 0.49% 60
2019
Q3
$816K Buy
10,094
+172
+2% +$13.8K 0.5% 55
2019
Q2
$799K Sell
9,922
-76
-0.8% -$5.82K 0.48% 58
2019
Q1
$799K Buy
9,998
+653
+7% +$48.8K 0.53% 51
2018
Q4
$682K Buy
9,345
+8,821
+1,683% +$623K 0.51% 59
2018
Q3
$36K Hold
524
0.02% 193
2018
Q2
$31K Hold
524
0.02% 197
2018
Q1
$27K Hold
524
0.02% 214
2017
Q4
$28K Buy
+524
New +$29.1K 0.02% 198

Other funds holding MRK

NVWM LLC's MRK Position: Q2 2026 in Review

NVWM LLC reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $52.4K and leaving 32,439 shares worth $4.17M. The position accounts for 0.84% of the portfolio, ranked #30.

NVWM LLC first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • NVWM LLC held 32,439 shares of Merck worth $4.17M as of Q2 2026.
  • NVWM LLC sold 448 Merck shares in Q2 2026, an estimated $52.4K.
  • Merck made up 0.84% of NVWM LLC's portfolio in Q2 2026, its #30 holding.
  • NVWM LLC first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.